Company Overview of Quanterix Corporation
Quanterix Corporation develops and provides ultra-sensitive diagnostic platform for measuring individual proteins. The company offers Single Molecule Array technology that enables the detection and quantification of biomarkers in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more; assay kits; and consumables. Its products are used in life science research, oncology, neurology, inflammatory disease, and infectious disease applications. Quanterix Corporation was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. The company was founded in 2007 and is based in Lexington, Massachusetts.
13 Hartwell Avenue
Lexington, MA 02421
Founded in 2007
Key Executives for Quanterix Corporation
Executive Chairman and Chief Executive Officer
Co-Founder, Chairman of Scientific Advisory Board and Director
Chief Financial Officer and Vice President of Finance & Administration
Chief Technology Officer and Vice President of Research
Director of Business Development and Strategic Collaborations
Compensation as of Fiscal Year 2015.
Quanterix Corporation Key Developments
Quanterix Announces Expansion into Asia Pacific
Jan 27 16
Quanterix Corporation announced that its expansion into several prominent APAC markets. With this expansion, Quanterix is meeting a huge, unmet demand for the company’s Simoa technology in Japan, China, Singapore, Malaysia, and Thailand, most recently naming Cold Spring Biotech as its official and exclusive distributor in China. With offices in Beijing, Shanghai, Guangzhou, and other cities in China, Cold Spring Biotech Corp. distributes instruments, reagents, and consumables for some the biggest manufacturers in the biotechnology market. In addition to its distribution services, Cold Spring Biotech provides R&D consultation services on research projects and experimental techniques. Quanterix first executed on its commercial strategy to expand into Asia earlier this year, announcing its entry into Japan, working with their exclusive distributor SCRUM Inc., of Tokyo. Now, the company has expanded into China markets, naming Cold Spring Biotech as their exclusive distributor, where they already have several orders pending. Quanterix also recently appointed Research Instruments for distribution in Singapore, Thailand and Malaysia and will continue this expansion into Asian markets in 2016.
Quanterix Seeks Acquisitions And Plans IPO
Jan 26 16
Quanterix Corporation is expanding into Asia while at the same time plotting a potential public stock sale later 2016. The timing of the IPO will depend on market conditions and acquisition opportunities, Kevin Hrusovsky, Chief Executive Officer and executive Chairman said.
Quanterix Corporation Presents at JPMorgan 34th Annual Healthcare Conference, Jan-12-2016 02:30 PM
Jan 6 16
Quanterix Corporation Presents at JPMorgan 34th Annual Healthcare Conference, Jan-12-2016 02:30 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Kevin Hrusovsky, Executive Chairman and Chief Executive Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|